Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) saw a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 2,220,000 shares, a growth of 16.2% from the February 28th total of 1,910,000 shares. Based on an average daily volume of 735,500 shares, the short-interest ratio is presently 3.0 days.
Axon Enterprise Trading Up 0.4 %
AXON opened at $217.70 on Friday. The firm has a market capitalization of $15.86 billion, a P/E ratio of 106.72 and a beta of 0.92. The firm’s 50 day moving average is $204.24 and its 200-day moving average is $175.11. Axon Enterprise has a 52-week low of $82.49 and a 52-week high of $226.00. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.53.
Insiders Place Their Bets
In other Axon Enterprise news, CEO Patrick W. Smith sold 71,499 shares of the firm’s stock in a transaction dated Tuesday, January 17th. The shares were sold at an average price of $185.77, for a total transaction of $13,282,369.23. Following the sale, the chief executive officer now directly owns 2,254,734 shares of the company’s stock, valued at approximately $418,861,935.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Patrick W. Smith sold 71,499 shares of the firm’s stock in a transaction that occurred on Tuesday, January 17th. The shares were sold at an average price of $185.77, for a total value of $13,282,369.23. Following the sale, the chief executive officer now directly owns 2,254,734 shares of the company’s stock, valued at $418,861,935.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 591 shares of the firm’s stock in a transaction that occurred on Friday, March 3rd. The stock was sold at an average price of $212.52, for a total transaction of $125,599.32. Following the completion of the sale, the director now directly owns 8,179 shares in the company, valued at $1,738,201.08. The disclosure for this sale can be found here. Insiders have sold 378,688 shares of company stock valued at $72,737,184 in the last ninety days. Insiders own 6.90% of the company’s stock.
Institutional Trading of Axon Enterprise
Hedge funds have recently made changes to their positions in the company. ICA Group Wealth Management LLC bought a new stake in shares of Axon Enterprise in the fourth quarter worth $25,000. IFP Advisors Inc increased its stake in shares of Axon Enterprise by 36.8% in the third quarter. IFP Advisors Inc now owns 364 shares of the biotechnology company’s stock worth $28,000 after buying an additional 98 shares during the last quarter. U.S. Capital Wealth Advisors LLC bought a new stake in shares of Axon Enterprise in the fourth quarter worth $29,000. SJS Investment Consulting Inc. bought a new stake in shares of Axon Enterprise in the third quarter worth $30,000. Finally, Roble Belko & Company Inc bought a new stake in shares of Axon Enterprise in the fourth quarter worth $33,000. Hedge funds and other institutional investors own 75.62% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts recently issued reports on AXON shares. Barclays raised their target price on shares of Axon Enterprise from $177.00 to $222.00 and gave the stock an “overweight” rating in a research report on Thursday, March 2nd. Robert W. Baird raised their price target on shares of Axon Enterprise from $200.00 to $237.00 and gave the company an “outperform” rating in a report on Wednesday, March 1st. Craig Hallum raised their price target on shares of Axon Enterprise from $215.00 to $242.00 in a report on Wednesday, March 1st. JMP Securities raised their price target on shares of Axon Enterprise from $195.00 to $235.00 and gave the company a “market outperform” rating in a report on Wednesday, February 1st. Finally, StockNews.com initiated coverage on shares of Axon Enterprise in a report on Thursday, March 16th. They issued a “hold” rating on the stock. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $221.64.
Axon Enterprise Company Profile
Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
